Have a feature idea you'd love to see implemented? Let us know!

AWH Aspira Women's Health Inc

Price (delayed)

$0.75

Market cap

$12.5M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.17

Enterprise value

$12.51M

Aspira Women's Health Inc. operates as a biotech company. The Company develops and discovers testing and treatments for gynecologic issues. Aspira Women's Health serves customers in the State of Texas.

Highlights
The EPS has grown by 43% YoY and by 18% from the previous quarter
The company's equity rose by 32% QoQ
The company's quick ratio has shrunk by 54% YoY but it rose by 41% QoQ
Aspira Women's Health's revenue has decreased by 2.3% YoY

Key stats

What are the main financial stats of AWH
Market
Shares outstanding
16.67M
Market cap
$12.5M
Enterprise value
$12.51M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
N/A
Price to sales (P/S)
1.29
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.4
Earnings
Revenue
$8.96M
EBIT
-$14.78M
EBITDA
-$14.66M
Free cash flow
-$14.59M
Per share
EPS
-$1.17
Free cash flow per share
-$0.95
Book value per share
-$0.16
Revenue per share
$0.58
TBVPS
$0.31
Balance sheet
Total assets
$4.76M
Total liabilities
$7.28M
Debt
$2.14M
Equity
-$2.52M
Working capital
-$1.35M
Liquidity
Debt to equity
-0.85
Current ratio
0.75
Quick ratio
0.62
Net debt/EBITDA
0
Margins
EBITDA margin
-163.6%
Gross margin
58.1%
Net margin
-165.1%
Operating margin
-189.5%
Efficiency
Return on assets
-267.2%
Return on equity
N/A
Return on invested capital
-4,812.7%
Return on capital employed
N/A
Return on sales
-164.8%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

AWH stock price

How has the Aspira Women's Health stock price performed over time
Intraday
-5.06%
1 week
-15.73%
1 month
-12.79%
1 year
-77.61%
YTD
-81.62%
QTD
-7.41%

Financial performance

How have Aspira Women's Health's revenue and profit performed over time
Revenue
$8.96M
Gross profit
$5.21M
Operating income
-$16.98M
Net income
-$14.8M
Gross margin
58.1%
Net margin
-165.1%
The net income has grown by 19% year-on-year and by 7% since the previous quarter
The net margin has increased by 17% year-on-year and by 8% since the previous quarter
The operating income has grown by 14% year-on-year and by 2.1% since the previous quarter
Aspira Women's Health's operating margin has increased by 12% YoY and by 2.6% from the previous quarter

Growth

What is Aspira Women's Health's growth rate over time

Valuation

What is Aspira Women's Health stock price valuation
P/E
N/A
P/B
N/A
P/S
1.29
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.4
The EPS has grown by 43% YoY and by 18% from the previous quarter
The company's equity rose by 32% QoQ
AWH's price to sales (P/S) is 96% less than its 5-year quarterly average of 36.6 and 56% less than its last 4 quarters average of 2.9
Aspira Women's Health's revenue has decreased by 2.3% YoY

Efficiency

How efficient is Aspira Women's Health business performance
Aspira Women's Health's ROIC has plunged by 169% YoY and by 82% from the previous quarter
The ROA has plunged by 66% YoY and by 9% from the previous quarter
The ROS has grown by 17% YoY and by 8% from the previous quarter

Dividends

What is AWH's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for AWH.

Financial health

How did Aspira Women's Health financials performed over time
Aspira Women's Health's total assets is 35% less than its total liabilities
The company's quick ratio has shrunk by 54% YoY but it rose by 41% QoQ
The company's current ratio fell by 49% YoY but it rose by 25% QoQ
The debt is 185% greater than the equity
Aspira Women's Health's debt to equity has soared by 76% YoY but it has decreased by 33% from the previous quarter
The company's equity rose by 32% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified. Data from and Sharadar.